T. Rowe Price Associates’s Celestica CLS Stock Holding History

T. Rowe Price Associates’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$366M	Buy	1,299,896 +612,547	+89%	+$178M	0.04%	320
2025 Q4	$203M	Buy	687,349 +305,265	+80%	+$92M	0.02%	460
2025 Q3	$94.1M	Buy	382,084 +86,426	+29%	+$17.4M	0.01%	635
2025 Q2	$46.2M	Buy	295,658 +91,802	+45%	+$9.76M	0.01%	750
2025 Q1	$16.1M	Sell	203,856 -65,522	-24%	-$6.95M	﹤0.01%	1001
2024 Q4	$24.9M	Buy	269,378 +106,931	+66%	+$8.36M	﹤0.01%	944
2024 Q3	$8.3M	Sell	162,447 -4,025,022	-96%	-$208M	﹤0.01%	1174
2024 Q2	$240M	Sell	4,187,469 -4,516,273	-52%	-$228M	0.03%	387
2024 Q1	$391M	Buy	8,703,742 +8,368,293	+2,495%	+$318M	0.05%	314
2023 Q4	$9.82M	Buy	+335,449	New	+$8.92M	﹤0.01%	1099

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return

T. Rowe Price Associates's CLS Position: Q1 2026 in Review

T. Rowe Price Associates increased its Celestica (CLS) stake by 89% in Q1 2026, buying an estimated $178M and bringing the position to 1,299,896 shares worth $366M. The position accounts for 0.04% of the portfolio, ranked #320.

T. Rowe Price Associates first reported a position in CLS in Q4 2023 and has held it in 10 quarters since. The position peaked at $391M in Q1 2024. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

T. Rowe Price Associates held 1,299,896 shares of Celestica worth $366M as of Q1 2026.
T. Rowe Price Associates bought 612,547 Celestica shares in Q1 2026, an estimated $178M.
Celestica made up 0.04% of T. Rowe Price Associates's portfolio in Q1 2026, its #320 holding.
T. Rowe Price Associates first reported a position in Celestica in Q4 2023 and has held it in 10 quarters since.
T. Rowe Price Associates's Celestica position peaked at $391M in Q1 2024.
773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.